Moody Aldrich Partners LLC Bicycle Therapeutics PLC Transaction History

Moody Aldrich Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$41.7 - $61.14 $2.46 Million - $3.61 Million	-59,053 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$27.95 - $44.24 $392,837 - $621,793	-14,055 Reduced 19.22%	59,053 $2.46 Million
Q2 2021 Aug 04, 2021	SELL	$27.0 - $32.28 $25,704 - $30,730	-952 Reduced 1.29%	73,108 $2.22 Million
Q1 2021 May 10, 2021	BUY	$19.12 - $30.25 $20,401 - $32,276	1,067 Added 1.46%	74,060 $2.21 Million
Q4 2020 Feb 16, 2021	BUY	$17.95 - $21.36 $1.31 Million - $1.56 Million	72,993 New	72,993 $1.31 Million

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.